Theracule SARL logo

Theracule SARL

Theracule Sarl is a personalized drug discovery and orphan drug development company for genetic forms of epilepsy and neurodegenerative diseases.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.theracule.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
9, avenue des Hauts-FourneauxL - 4362
Alzette
Luxembourg
Email
Contact Number
+352 46 66 44 6295

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]

Theracule has developed an in vivo drug discovery platform using zebrafish and mouse models for orphan drug development. Initial efforts focus on developing drugs for the third of epilepsy patients who are resistant to existing epilepsy drugs. Theracules pipeline starts by identifying common gene mutations among PRE patients for which genetically equivalent zebrafish and mouse models are created. These zebrafish, which display epilepsy-like phenotypes, are screened against thousands of chemical compounds.